Blog

MBF Therapeutics Teams Up With Wistar

December 1, 2016

A Montgomery County company seeking to develop ways to treat cancer in dogs and cats has secured a new partner and new investment to help it achieve its goals. MBF Therapeutics of Ambler raised more than $100,000 in new capital from private investors and converted existing debt and notes into equity in a $1.1 million […]

Read More

BBC’s ‘100 Women 2016’ List Features ROAR for Good’s Yasmine Mustafa

November 23, 2016

As ROAR for Good keeps working on its flagship Athena product (slated to ship early 2017, last time we checked), CEO Yasmine Mustafa landed some more press. This time, it’s international, thanks to a spot on BBC’s 100 Women 2016 list, published on Monday. “I was speechless when I first got the news in August […]

Read More

MilkCrate for Communities comes to Philadelphia University

November 23, 2016

A week from Thanksgiving, MilkCrate CEO Morgan Berman published an article titled “A bevy of thank yous and news” in which she announced the company would be pivoting toward a business to-business model under the MilkCrate for Communities platform. “Free sustainable lifestyle consumer app? Not anymore! Welcome to the world of B2B enterprise software and the […]

Read More

See Which Companies Made the Final Cut to Pitch Investors at IMPACT 2016

November 17, 2016

The major mid-atlantic capital investment conference IMPACT will kick off in just four weeks in Philadelphia, bringing together more than a thousand players from the venture capital, private equity and entrepreneurship communities for the day-and-a-half conference. IMPACT, run by Philadelphia Alliance for Capital Technologies, or PACT, gives up and coming companies the chance to present […]

Read More

Greenphire Is Upgrading Clinical Trials Worldwide

November 16, 2016

Who knew clinical trials were still so stuck in the past? Besides the big ethical questions the studies raise, enrollees also face a number of taxing hurdles that can sometimes bar participation. For those with rare orphan diseases, for example, just traveling to the studies can be a financial and logistical nightmare. And when it’s […]

Read More

Previous Next